Form 8-K DNA X, Inc. For: Jun 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/19/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Medifast launches Trilivy, replacing its Optavia brand
- Adobe has received a takeover approach by a Big Tech company - Betaville
DNA X raises $8.1M via preferred stock sale to related-party investor
July 2, 2026 8:58 AM EDTDNA X, Inc. (NASDAQ: SONM), formerly known as Sonim Technologies, entered into a securities purchase agreement on June 29, 2026, to sell 1,346,531 shares of Series B Convertible Preferred Stock to DNA Holdings Venture, Inc. at $6.00 per share, for an aggregate offering price of $8.1 million.
DNA Holdings is both a holder of more than 5% of the company's outstanding capital stock and an... More
